[Yanzhou Coal Mining Company Limited Date Zhang Baocai Director 2 This announcement is not an offer to purchase, a solicitation of an offer to purchase, or a solicitation of an offer to sell, the Notes. This announcement does not constitute, and may not be used in connection with, any form of offer or solicitation in any place where such offers]
[Yanzhou Coal Mining Company Limited Date Zhang Baocai Director 2 This announcement is not an offer to purchase, a solicitation of an offer to purchase, or a solicitation of an offer to sell, the Notes. This announcement does not constitute, and may not be used in connection with, any form of offer or solicitation in any place where such offers]
[Yanzhou Coal Mining Company Limited Date Zhang Baocai]
[Yanzhou Coal Mining Company Limited Date Zhang Baocai]
[Melco Crown Entertainment Announces Unaudited First Quarter 2016 Earnings and Declares Quarterly Dividend Macau, Wednesday, May 4, 2016 Melco Crown Entertainment Company we Net revenue for the first quarter of 2016 was US$1,103.6 million, representing an increase of approximately 5% from US$1,054.3 million for the comparable period in 2015. The increase in net revenue was primarily attributable to the net] [Form 6K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]
[FOR RELEASE May 4, 2016 China Biologic Reports Financial Results for the First Quarter of 2016 1Q16 Total Sales Up 29.4% with Non-GAAP Net Income Up 29.8% YoY in RMB terms, or Up 21.6% YoY to $85.6 Million and 21.6% YoY to $30.4 Million in USD terms, respectively BEIJING, China – May 4, 2016 – First Quarter 2016 Financial Highlights] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 4, 2016 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3111 ____________________________________________________________ (Former name or former]
[Melco Crown Entertainment Announces Unaudited First Quarter 2016 Earnings and Declares Quarterly Dividend Macau, Wednesday, May 4, 2016 Melco Crown Entertainment Company we Net revenue for the first quarter of 2016 was US$1,103.6 million, representing an increase of approximately 5% from US$1,054.3 million for the comparable period in 2015. The increase in net revenue was primarily attributable to the net] [Form 6K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]
[FOR RELEASE May 4, 2016 China Biologic Reports Financial Results for the First Quarter of 2016 1Q16 Total Sales Up 29.4% with Non-GAAP Net Income Up 29.8% YoY in RMB terms, or Up 21.6% YoY to $85.6 Million and 21.6% YoY to $30.4 Million in USD terms, respectively BEIJING, China – May 4, 2016 – First Quarter 2016 Financial Highlights] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 4, 2016 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3111 ____________________________________________________________ (Former name or former]
[Melco Crown Entertainment Announces Privately Negotiated Share Repurchase Macau, Wednesday, May 4, 2016 Melco Crown Entertainment Company CAI Crown Melco Prior to the transaction, CAI owned approximately 559.3 million shares, or approximately 34.3%, of the Companys outstanding shares. Following the transaction, CAI will own approximately 404.3 million shares, or approximately 27.4% of the Company, and the shareholding of Melco International] [MELCO CROWN ENTERTAINMENT LIMITED Form 6K MELCO CROWN ENTERTAINMENT LIMITED Stephanie Cheung Chief Legal Officer and Company Secretary 3 Description 99.1 Melco Crown Entertainment Announces Privately Negotiated Share Repurchase 6-K 1 d183357d6k.htm FORM 6-K]
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]
